Posted inBiotechnology
Posted inBiotechnology
Fibrosis-focused Tvardi to go public via merger with cash-strapped Cara
Pruritus drug developer Cara Therapeutics kicked off the year halving its headcount, and the biotech has now found a new…




![high-contrast-[¹⁸f]sitate-pet/ct-imaging-maps-somatostatin-receptors-in-meningiomas](https://biotechgrid.com/wp-content/uploads/2026/08/44773-high-contrast-80821-pet-ct-imaging-maps-somatostatin-receptors-in-meningiomas.jpg)













